S. Eichau
AuthID: R-00J-2BP
1
TÃTULO: Improvements with Alemtuzumab in clinical and MRI disease activity outcomes in RRMS patients across age groups: CARE-MS I and II 8-year follow-up Full Text
AUTORES: Eichau, S; Arroyo, R; Bass, AD; Boster, A; Boyko, AN; Graves, D; Ionete, C; Limmroth, V; Navas, C; Pelletier, D; Pozzilli, C; Ravenscroft, J; Sousa, L; Tintore, M; Uitdehaag, BM; Baker, DP; Daizadeh, N; Choudhry, Z; Rog, D;
PUBLICAÇÃO: 2019, FONTE: 5th Congress of the European-Academy-of-Neurology (EAN) in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 26
AUTORES: Eichau, S; Arroyo, R; Bass, AD; Boster, A; Boyko, AN; Graves, D; Ionete, C; Limmroth, V; Navas, C; Pelletier, D; Pozzilli, C; Ravenscroft, J; Sousa, L; Tintore, M; Uitdehaag, BM; Baker, DP; Daizadeh, N; Choudhry, Z; Rog, D;
PUBLICAÇÃO: 2019, FONTE: 5th Congress of the European-Academy-of-Neurology (EAN) in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 26
INDEXADO EM: 
WOS
WOS